Search - tctmd.com

Displaying 421 - 440 of 448

Sort: Relevancy | Date

News Conference News ESC 2012

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

August 26, 2012

News Daily News

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

L.A. McKeown

August 15, 2012

News Daily News

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

August 14, 2012

News Daily News

Indirect Comparisons Show Little Difference Among New Anticoagulants

August 14, 2012

News Daily News

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

L.A. McKeown

August 09, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Daily News

Rivaroxaban May be Cost-Effective for A-fib Patients

L.A. McKeown

June 06, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

News Daily News

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

May 09, 2012

News Daily News

Una Dosis Alta de Recarga de Prasugrel es Mejor a la hora de Suprimir la Reactividad Plaquetaria que Antecede a una PCI

Jason Kahn

May 01, 2012

News Daily News

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

April 10, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

L.A. McKeown

March 12, 2012

News Daily News

Relación Hemorragia Intrahospitalaria/Mortalidad tras Sufrir un NSTEMI

Caitlin E. Cox

March 12, 2012

News Daily News

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

Caitlin E. Cox

March 06, 2012

News Daily News

COURAGE Substudy: Treat the Components, Not the Syndrome

March 06, 2012

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Novel Anticoagulants Showing Benefits in A-fib Subgroups

August 29, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Conference News

Different Agents Show Potential as Adjuncts to PCI

Jason Kahn

May 19, 2011

Advertisement

Comparable Long-Term Safety, Efficacy with Prasugrel, Clopidogrel in ACS

PCI, Surgery Show Similar Long-term Mortality in Diabetic, Nondiabetic Patients

No Safe Window for Triple Antithrombotic Therapy in High-Risk A-fib Patients

Indirect Comparisons Show Little Difference Among New Anticoagulants

Updated Guidelines Support New Antithrombotics as Warfarin Alternatives in A-fib

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

Rivaroxaban May be Cost-Effective for A-fib Patients

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

HORIZONS-AMI: More Fallout When Stent Thrombosis Happens In-Hospital

Una Dosis Alta de Recarga de Prasugrel es Mejor a la hora de Suprimir la Reactividad Plaquetaria que Antecede a una PCI

CHARISMA Genetics Analysis: CYP2C19 Variants Show Little Clinical Impact

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

Relación Hemorragia Intrahospitalaria/Mortalidad tras Sufrir un NSTEMI

PLATO Analysis: PPIs Problematic with Both Ticagrelor, Clopidogrel

COURAGE Substudy: Treat the Components, Not the Syndrome

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Novel Anticoagulants Showing Benefits in A-fib Subgroups

Ticagrelor Gains FDA Approval for Use in ACS

Different Agents Show Potential as Adjuncts to PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content